标题
Critical clinical gaps in cancer precision nanomedicine development
作者
关键词
Cancer, Cellular receptor, Metabolizing enzyme, Nanomedicine, Omics, Precision medicine
出版物
JOURNAL OF CONTROLLED RELEASE
Volume 345, Issue -, Pages 811-818
出版商
Elsevier BV
发表日期
2022-04-02
DOI
10.1016/j.jconrel.2022.03.055
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Salvadora persica attenuates DMBA-induced mammary cancer through downregulation oxidative stress, estrogen receptor expression and proliferation and augmenting apoptosis
- (2022) Alaaeldin Ahmed Hamza et al. BIOMEDICINE & PHARMACOTHERAPY
- Increased co-expression of PSMA2 and GLP-1 receptor in cervical cancer models in type 2 diabetes attenuated by Exendin-4: A translational case-control study
- (2021) Dandan Mao et al. EBioMedicine
- Promoter hypermethylation regulates vitamin D receptor (VDR) expression in colorectal cancer-A study from Kashmir valley
- (2021) Falaque Ul Afshan et al. Cancer Genetics
- Mitochondrial Voltage-Dependent Anion Channel 1–Hexokinase-II Complex-Targeted Strategy for Melanoma Inhibition Using Designed Multiblock Peptide Amphiphiles
- (2021) Fan Zhang et al. ACS Applied Materials & Interfaces
- Clustering of Death Receptor for Apoptosis Using Nanoscale Patterns of Peptides
- (2021) Yang Wang et al. ACS Nano
- A review of nanoparticle drug delivery systems responsive to endogenous breast cancer microenvironment
- (2021) Tengteng Zou et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Dietary 5-demethylnobiletin modulates xenobiotic-metabolizing enzymes and ameliorates colon carcinogenesis in benzo[a]pyrene-induced mice
- (2021) Ya-Chun Chou et al. FOOD AND CHEMICAL TOXICOLOGY
- Garlic oil blocks tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis by inducing phase II drug-metabolizing enzymes
- (2021) Lei Zhang et al. FOOD AND CHEMICAL TOXICOLOGY
- Androgen receptor expression in breast cancer: Implications on prognosis and treatment, a brief review
- (2021) Nusrat Jahan et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Recent Progress in Nanoscale Covalent Organic Frameworks for Cancer Diagnosis and Therapy
- (2021) Shuncheng Yao et al. Nano-Micro Letters
- To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives
- (2021) Da Shi et al. ADVANCED DRUG DELIVERY REVIEWS
- Expression of the CXCR4 and CXCR7 in renal cancers; can “the orphan receptor” predict the mortality?
- (2021) Milena Potić Floranović et al. Annals of Diagnostic Pathology
- Determinants of Resistance to Checkpoint Inhibitors
- (2020) Linda Tran et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Folate-induced nanostructural changes of oligochitosan nanoparticles and their fate of cellular internalization by melanoma
- (2020) Abdul Hadi Musalli et al. CARBOHYDRATE POLYMERS
- Dual Hypoxia-Targeting RNAi Nanomedicine for Precision Cancer Therapy
- (2020) Yujing Li et al. NANO LETTERS
- Aptamer-Equipped Protamine Nanomedicine for Precision Lymphoma Therapy
- (2020) Zihua Zeng et al. Cancers
- Corticotropin Releasing Factor Receptors in breast cancer: Expression and activity in hormone-dependent growth in vitro
- (2020) Maria Koureta et al. PEPTIDES
- Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6
- (2020) Pier Giorgio Cojutti et al. CLINICAL PHARMACOKINETICS
- Actively targeted nanomedicines for precision cancer therapy: Concept, construction, challenges and clinical translation
- (2020) Wenxing Gu et al. JOURNAL OF CONTROLLED RELEASE
- Targeting tumor‑associated macrophages in the tumor microenvironment (Review)
- (2020) Kaiwen Zhou et al. Oncology Letters
- Remotely Activated Nanoparticles for Anticancer Therapy
- (2020) Luisa Racca et al. Nano-Micro Letters
- Dextran-modified Quercetin-Cu(II)/hyaluronic acid nanomedicine with natural poly(ADP-ribose) polymerase inhibitor and dual targeting for programmed synthetic lethal therapy in triple-negative breast cancer
- (2020) Hung-Wei Cheng et al. JOURNAL OF CONTROLLED RELEASE
- Targeting Tumor Microenvironment for Cancer Therapy
- (2019) Catarina Roma-Rodrigues et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Impact of Ethnicity-Specific Hepatic Microsomal Scaling Factor, Liver Weight, and Cytochrome P450 (CYP) 1A2 Content on Physiologically Based Prediction of CYP1A2-Mediated Pharmacokinetics in Young and Elderly Chinese Adults
- (2019) Guo-Fu Li et al. CLINICAL PHARMACOKINETICS
- Modulation of CYP450 activities in patients with type 2 diabetes
- (2019) Sophie Gravel et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Exploiting vulnerabilities of cancer by targeting nuclear receptors of stromal cells in tumor microenvironment
- (2019) Hong Sheng Cheng et al. Molecular Cancer
- Absorption, distribution, metabolism and excretion of the biomaterials used in Nanocarrier drug delivery systems
- (2019) Chong Su et al. ADVANCED DRUG DELIVERY REVIEWS
- Determinants of nutrient limitation in cancer
- (2019) Mark R. Sullivan et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Advances in nanotechnology-based delivery systems for EGFR tyrosine kinases inhibitors in cancer therapy
- (2019) Xiaohan Zhou et al. Asian Journal of Pharmaceutical Sciences
- MON-PO372: The Effects of Gene Polymorphisms of Metabolic Enzymes on the Association Between Red and Processed Meat Consumption and the Development of Colon Cancer; a Literature Review
- (2019) S. Doaei et al. CLINICAL NUTRITION
- Results and challenges of Cytochrome P450 2D6 ( CYP2D6 ) testing in an ethnically diverse South Florida population
- (2019) Daria Salyakina et al. Molecular Genetics & Genomic Medicine
- A Review on Artificial Micro/Nanomotors for Cancer-Targeted Delivery, Diagnosis, and Therapy
- (2019) Jiajia Wang et al. Nano-Micro Letters
- Targeting the microenvironment in solid tumors
- (2018) Carmen Belli et al. CANCER TREATMENT REVIEWS
- Concern over cost of and access to cancer treatments: A meta-narrative review of nivolumab and pembrolizumab studies
- (2018) Cássia Rita Pereira da Veiga et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Disease-Drug Interactions in Inflammatory States via Effects on CYP-Mediated Drug Clearance
- (2018) David E. Coutant et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Therapeutically targeting tumor microenvironment–mediated drug resistance in estrogen receptor–positive breast cancer
- (2018) Kevin Shee et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting Gas6/TAM in cancer cells and tumor microenvironment
- (2018) Guiling Wu et al. Molecular Cancer
- A highly integrated precision nanomedicine strategy to target esophageal squamous cell cancer molecularly and physically
- (2018) Xin-shuai Wang et al. Nanomedicine-Nanotechnology Biology and Medicine
- Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases?
- (2018) Giuseppe Bronte et al. Translational Oncology
- Increase in hyaluronic acid degradation decreases the expression of estrogen receptor alpha in MCF7 breast cancer cell line
- (2018) Vincent Hanoux et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?
- (2018) Giorgia Marisi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Nanomedicine applications in the treatment of breast cancer: current state of the art
- (2017) Di Wu et al. International Journal of Nanomedicine
- Targeting NCAM-expressing neuroblastoma with polymeric precision nanomedicine
- (2017) Ela Markovsky et al. JOURNAL OF CONTROLLED RELEASE
- De-novo and acquired resistance to immune checkpoint targeting
- (2017) Nicholas L Syn et al. LANCET ONCOLOGY
- A review of endoplasmic reticulum (ER) stress and nanoparticle (NP) exposure
- (2017) Yi Cao et al. LIFE SCIENCES
- Nanoscale clustering of the neurotrophin receptor TrkB revealed by super-resolution STED microscopy
- (2017) Borislav Angelov et al. Nanoscale
- Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia
- (2017) Andreas Hochhaus et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nanomedicine approaches to improve cancer immunotherapy
- (2017) Hui Qiu et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Targeting the tumour microenvironment with an enzyme-responsive drug delivery system for the efficient therapy of breast and pancreatic cancers
- (2017) Brigitte Renoux et al. Chemical Science
- A genome-wide association study identifies a novel susceptibility locus for the immunogenicity of polyethylene glycol
- (2017) Chia-Jung Chang et al. Nature Communications
- Effects of chemotherapy agents on Sphingosine-1-Phosphate receptors expression in MCF-7 mammary cancer cells
- (2016) P. Ghosal et al. BIOMEDICINE & PHARMACOTHERAPY
- Nab-paclitaxel for the treatment of triple-negative breast cancer: Rationale, clinical data and future perspectives
- (2016) Francesco Schettini et al. CANCER TREATMENT REVIEWS
- Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials
- (2016) Joseph M. Caster et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Significant change of cytochrome P450s activities in patients with hepatocellular carcinoma
- (2016) Jun Zhou et al. Oncotarget
- Targeting microenvironment in cancer therapeutics
- (2016) Matthew Martin et al. Oncotarget
- Targeting folate receptor alpha for cancer treatment
- (2016) Anthony Cheung et al. Oncotarget
- Bismuth Sulfide Nanorods as a Precision Nanomedicine for in Vivo Multimodal Imaging-Guided Photothermal Therapy of Tumor
- (2015) Jing Liu et al. ACS Nano
- CYP2D6 Genetic Polymorphisms and Phenotypes in Different Ethnicities of Malaysian Breast Cancer Patients
- (2015) Fee Wai Chin et al. Breast Journal
- High CYP2C19 phenotypic variability in gastrointestinal cancer patients
- (2015) K. E. Burns et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Dual-Ligand Modified Polymer-Lipid Hybrid Nanoparticles for Docetaxel Targeting Delivery to Her2/neu Overexpressed Human Breast Cancer Cells
- (2015) Zhe Yang et al. Journal of Biomedical Nanotechnology
- Enhanced noscapine delivery using estrogen-receptor-targeted nanoparticles for breast cancer therapy
- (2014) Jitender Madan et al. ANTI-CANCER DRUGS
- Insight into nanoparticle cellular uptake and intracellular targeting
- (2014) Basit Yameen et al. JOURNAL OF CONTROLLED RELEASE
- Tumor-Targeting and Microenvironment-Responsive Smart Nanoparticles for Combination Therapy of Antiangiogenesis and Apoptosis
- (2013) Shixian Huang et al. ACS Nano
- Nanotechnology approaches for personalized treatment of multidrug resistant cancers
- (2013) Tamara Minko et al. ADVANCED DRUG DELIVERY REVIEWS
- Expression of folate receptors in nasopharyngeal and laryngeal carcinoma and folate receptor-mediated endocytosis by molecular targeted nanomedicine
- (2013) Xie et al. International Journal of Nanomedicine
- The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage
- (2013) Amr S. Abu Lila et al. JOURNAL OF CONTROLLED RELEASE
- From P0 to P6 medicine, a model of highly participatory, narrative, interactive, and “augmented” medicine: some considerations on Salvatore Iaconesi’s clinical story
- (2013) Nicola Bragazzi Patient Preference and Adherence
- Liposome: classification, preparation, and applications
- (2013) Abolfazl Akbarzadeh et al. Nanoscale Research Letters
- Regulation of leptin receptor expression in human papillary thyroid cancer cells
- (2012) Shih-Ping Cheng et al. BIOMEDICINE & PHARMACOTHERAPY
- Cytochrome P450 variations in different ethnic populations
- (2012) Joseph McGraw et al. Expert Opinion on Drug Metabolism & Toxicology
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- (2012) Sunil Verma et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Association between Cancer Risk and Drug-metabolizing Enzyme Gene (CYP2A6, CYP2A13, CYP4B1, SULT1A1, GSTM1 and GSTT1) Polymorphisms in Cases of Lung Cancer in Japan
- (2011) Yuichiro Tamaki et al. Drug Metabolism and Pharmacokinetics
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Predictive, personalized, preventive, participatory (P4) cancer medicine
- (2011) Leroy Hood et al. Nature Reviews Clinical Oncology
- The US FDAs withdrawal of the breast cancer indication for Avastin (bevacizumab)
- (2011) Larry D. Sasich et al. SAUDI PHARMACEUTICAL JOURNAL
- Tumor delivery of macromolecular drugs based on the EPR effect
- (2010) Vladimir Torchilin ADVANCED DRUG DELIVERY REVIEWS
- To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
- (2010) Fabienne Danhier et al. JOURNAL OF CONTROLLED RELEASE
- Association of cyclophosphamide drug–metabolizing enzyme polymorphisms and chemotherapy-related ovarian failure in breast cancer survivors
- (2009) H. Irene Su et al. FERTILITY AND STERILITY
- Endocytosisviacaveolae: alternative pathway with distinct cellular compartments to avoid lysosomal degradation?
- (2009) Anna L. Kiss et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- CYP2C19 pharmacogenetics in advanced cancer: compromised function independent of genotype
- (2008) N A Helsby et al. BRITISH JOURNAL OF CANCER
- Antibody-modified liposomes for cancer chemotherapy
- (2008) Vladimir Torchilin Expert Opinion on Drug Delivery
- Nanocarrier-assisted sub-cellular targeting to the site of mitochondria improves the pro-apoptotic activity of paclitaxel
- (2008) Gerard GM D'Souza et al. JOURNAL OF DRUG TARGETING
- Cancer is a Preventable Disease that Requires Major Lifestyle Changes
- (2008) Preetha Anand et al. PHARMACEUTICAL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search